久日新材(688199) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was CNY 422,988,893.15, representing a year-on-year increase of 35.84%[4] - The net profit attributable to shareholders was CNY 54,775,456.06, reflecting a growth of 43.22% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 81.57% to CNY 47,604,110.91[4] - Basic and diluted earnings per share were both CNY 0.51, marking a 50.00% increase from the previous year[4] - Net profit for Q1 2022 was ¥60,206,842.13, up 57.5% from ¥38,218,112.15 in Q1 2021[20] - Operating profit for Q1 2022 was ¥73,406,666.63, representing a 59.1% increase compared to ¥46,135,361.21 in Q1 2021[20] - The company reported a total comprehensive income of ¥55,065,668.79 for Q1 2022, compared to ¥37,729,683.16 in Q1 2021[21] Cash Flow - The net cash flow from operating activities reached CNY 37,454,291.96, a significant increase of 1,018.99% year-on-year[4] - In Q1 2022, the cash inflow from operating activities was CNY 392,723,047.60, a 60% increase from CNY 245,289,422.04 in Q1 2021[23] - The net cash flow from operating activities reached CNY 37,454,291.96, compared to CNY 3,347,151.62 in the same period last year, indicating significant improvement[24] - The total cash outflow from investing activities was CNY 709,559,382.35, up from CNY 486,423,258.31 in Q1 2021, resulting in a net cash outflow of CNY 244,329,279.32[24] - The cash inflow from financing activities was CNY 254,143,747.32, compared to CNY 86,205,179.02 in Q1 2021, showing a substantial increase[24] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,093,240,885.23, up 5.97% from the end of the previous year[5] - The company's current assets totaled RMB 2,214,390,862.45, compared to RMB 2,082,661,951.33 at the end of 2021, indicating an increase of about 6.34%[17] - The total liabilities as of Q1 2022 amounted to ¥1,197,871,927.27, compared to ¥1,024,363,104.63 in Q1 2021, reflecting a 16.9% increase[19] - The company's total liabilities increased to CNY 514,067,191.69 from CNY 485,965,717.47 at the end of 2021[27] - The total equity decreased to CNY 2,576,076,531.22 from CNY 2,582,186,339.85 at the end of 2021[28] Research and Development - Research and development expenses amounted to CNY 21,208,575.74, accounting for 5.01% of operating revenue, a decrease of 0.46 percentage points[5] - Research and development expenses for Q1 2022 totaled ¥21,208,575.74, an increase from ¥17,031,304.12 in Q1 2021[19] - Research and development expenses increased to ¥5,092,449.04 in Q1 2022, up 37.8% from ¥3,696,077.63 in Q1 2021[30] Subsidiaries and Investments - The company’s subsidiary, Hunan Jiuri, contributed to revenue growth following the acquisition of Hongrun Chemical at the end of 2021[9] - The company’s subsidiary, Inner Mongolia Jiuri New Materials Co., Ltd., has commenced production for a new project with an annual capacity of 9,250 tons of photoinitiators and intermediates, which began trial operations on March 15, 2022[15] - The company reported a significant increase in trading financial assets, which rose to RMB 341,343,692.70 from RMB 100,290,000.00, indicating a growth of approximately 240.5%[16] - The company’s long-term equity investments increased slightly to RMB 122,947,518.86 from RMB 122,444,752.95, reflecting a growth of about 0.41%[17] - The company’s investment income for Q1 2022 was ¥4,174,626.19, a significant drop from ¥192,625,232.09 in Q1 2021[30]